| Autor: |
Hauptman, Megan, Krase, Jeffrey M. |
| Předmět: |
|
| Zdroj: |
Dermatology Online Journal; 2020, Vol. 26 Issue 12, p1-3, 3p |
| Abstrakt: |
Pemphigus vulgaris is the most common form of pemphigus affecting an estimated 30,000-40,000 people in the United States. Costs of systemic and immunoglobulin therapies for pemphigus vulgaris have remained persistently high. Herein, we address the current costs and changes in costs of immunosuppressive treatments, anti-inflammatory treatments, and immunoglobulin treatments covered by Medicaid for pemphigus vulgaris from 2013-2020. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
